Funding: Donor drugs

Subsidizing the Distribution Channel: Donor Funding to Improve the Availability of Malaria Drugs

In countries that bear the heaviest burden of malaria, most patients seek medicine for the disease in the private sector. Because the availability and affordability of recommended malaria drugs provided by the private-sector distribution channel is poor, donors (e.g., the Global Fund) are devoting substantial resources to fund subsidies that encourage the channel to improve access to these drug...

Vital breast cancer drugs highlight funding ethics.

Changing Donor Funding and the Challenges of Integrated HIV Treatment.

Donor financing for HIV prevention and treatment has shifted from supporting disease-specific ("vertical") programs to health systems strengthening ("horizontal") programs intended to integrate all aspects of care. We examine the consequences of shifting resources from three perspectives: first, through a broad analysis of the changing policy context of health care financing; second, through an...

LITERATURE REVIEW OF OTHER DONOR FUNDING OF NGOs

Donor Funding for Newborn Survival: An Analysis of Donor-Reported Data, 2002–2010

BACKGROUND Neonatal mortality accounts for 43% of global under-five deaths and is decreasing more slowly than maternal or child mortality. Donor funding has increased for maternal, newborn, and child health (MNCH), but no analysis to date has disaggregated aid for newborns. We evaluated if and how aid flows for newborn care can be tracked, examined changes in the last decade, and considered met...